Shanghai Shyndec Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Shyndec Pharmaceutical Co Ltd with three other
companies in this sector in China:
Harbin Gloria Pharmaceuticals Co., Ltd
sales of 2.70 billion Chinese Renmimbi [US$400.72 million]
of which 85%
was Pharmaceutical Manufacturing),
Jiangsu Kanion Pharmaceutical Co., Ltd.
(2.82 billion Chinese Renmimbi [US$418.57 million]
of which 100%
was Exportation Trade), and
Jiangzhong Pharmaceutical Company Limited
(2.60 billion Chinese Renmimbi [US$385.28 million]
of which 68%
was Medical Industry).
During the year ended December of 2015, sales at
Shanghai Shyndec Pharmaceutical Co Ltd were 2.68 billion Chinese Renmimbi (US$398.05 million).
decrease of 2.4%
versus 2014, when the company's sales were 2.75 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 99.1% decline
in Trade, from 211.29 million Chinese Renmimbi to 1.95 million Chinese Renmimbi.
There were also decreases in sales in
Information Services (down 10.2% to 25.14 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Drug Products (up 2.8% to 1.99 billion Chinese Renmimbi)
Raw Material (up 13.7% to 652.68 million Chinese Renmimbi)